• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种克服抗生素耐药菌的新方法:基于肠道微生物群的中药疗法。

A new approach to overcoming antibiotic-resistant bacteria: Traditional Chinese medicine therapy based on the gut microbiota.

机构信息

Medical School of Nantong University, Nantong, Jiangsu, China.

Center for Basic Medical Research, Medical School of Nantong University, Nantong, Jiangsu, China.

出版信息

Front Cell Infect Microbiol. 2023 Apr 6;13:1119037. doi: 10.3389/fcimb.2023.1119037. eCollection 2023.

DOI:10.3389/fcimb.2023.1119037
PMID:37091671
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10117969/
Abstract

With the irrational use of antibiotics and the increasing abuse of oral antibiotics, the drug resistance of gastrointestinal pathogens has become a prominent problem in clinical practice. Gut microbiota plays an important role in maintaining human health, and the change of microbiota also affects the activity of pathogenic bacteria. Interfering with antibiotic resistant bacteria by affecting gut microbiota has also become an important regulatory signal. In clinical application, due to the unique advantages of traditional Chinese medicine in sterilization and drug resistance, it is possible for traditional Chinese medicine to improve the gut microbial microenvironment. This review discusses the strategies of traditional Chinese medicine for the treatment of drug-resistant bacterial infections by changing the gut microenvironment, unlocking the interaction between microbiota and drug resistance of pathogenic bacteria.

摘要

随着抗生素的不合理使用和口服抗生素的滥用,胃肠道病原体的耐药性已成为临床实践中的突出问题。肠道微生物群在维持人体健康方面发挥着重要作用,微生物群的变化也会影响致病菌的活性。通过影响肠道微生物群来干扰耐药菌也成为一种重要的调节信号。在临床应用中,由于中药在杀菌和耐药方面具有独特的优势,因此中药有可能改善肠道微生物微环境。本综述讨论了通过改变肠道微环境来治疗耐药菌感染的中药策略,揭示了微生物群与致病菌耐药性之间的相互作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfa2/10117969/284e4f59e3e9/fcimb-13-1119037-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfa2/10117969/9ef0e73d69b1/fcimb-13-1119037-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfa2/10117969/284e4f59e3e9/fcimb-13-1119037-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfa2/10117969/9ef0e73d69b1/fcimb-13-1119037-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfa2/10117969/284e4f59e3e9/fcimb-13-1119037-g002.jpg

相似文献

1
A new approach to overcoming antibiotic-resistant bacteria: Traditional Chinese medicine therapy based on the gut microbiota.一种克服抗生素耐药菌的新方法:基于肠道微生物群的中药疗法。
Front Cell Infect Microbiol. 2023 Apr 6;13:1119037. doi: 10.3389/fcimb.2023.1119037. eCollection 2023.
2
Antibiotic Resistance and Microbiota Response.抗生素耐药性与微生物组反应。
Curr Pharm Des. 2023;29(5):356-364. doi: 10.2174/1381612829666221219093450.
3
Gut microbiota: A new target for traditional Chinese medicine in the treatment of depression.肠道微生物群:中医药治疗抑郁症的新靶点。
J Ethnopharmacol. 2023 Mar 1;303:116038. doi: 10.1016/j.jep.2022.116038. Epub 2022 Dec 15.
4
Crosstalk between traditional Chinese medicine-derived polysaccharides and the gut microbiota: A new perspective to understand traditional Chinese medicine.中药多糖与肠道微生物群的相互作用:理解中药的新视角。
Phytother Res. 2022 Nov;36(11):4125-4138. doi: 10.1002/ptr.7607. Epub 2022 Sep 13.
5
Targeted modulation of gut microbiota by traditional Chinese medicine and natural products for liver disease therapy.中药和天然产物靶向调节肠道微生物群治疗肝脏疾病。
Front Immunol. 2023 Feb 2;14:1086078. doi: 10.3389/fimmu.2023.1086078. eCollection 2023.
6
Colonization resistance against multi-drug-resistant bacteria: a narrative review.抗多重耐药菌定植的研究进展:一项综述。
J Hosp Infect. 2021 Dec;118:48-58. doi: 10.1016/j.jhin.2021.09.001. Epub 2021 Sep 4.
7
Eubiotic properties of rifaximin: Disruption of the traditional concepts in gut microbiota modulation.利福昔明的益生元特性:对肠道微生物群调节传统观念的颠覆。
World J Gastroenterol. 2017 Jul 7;23(25):4491-4499. doi: 10.3748/wjg.v23.i25.4491.
8
The Gut Microbiota and Traditional Chinese Medicine: A New Clinical Frontier on Cancer.肠道微生物群与中医药:癌症的新临床前沿。
Curr Drug Targets. 2021;22(11):1222-1231. doi: 10.2174/1389450122666210412141304.
9
Gut microbiome signatures and host colonization with multidrug-resistant bacteria.肠道微生物组特征与多药耐药菌的宿主定植。
Trends Microbiol. 2022 Sep;30(9):853-865. doi: 10.1016/j.tim.2022.01.013. Epub 2022 Feb 18.
10
[Role of the gut microbiome in the development and transfer of antibiotic resistances].[肠道微生物群在抗生素耐药性的产生和传播中的作用]
Inn Med (Heidelb). 2022 Oct;63(10):1043-1050. doi: 10.1007/s00108-022-01400-1. Epub 2022 Sep 1.

引用本文的文献

1
Preliminary Multi-Omics Insights into Green Alternatives to Antibiotics: Effects of , , and on Gut Health and Metabolic Regulation in Chickens.抗生素绿色替代品的初步多组学见解:[此处可能缺失具体物质名称]、[此处可能缺失具体物质名称]和[此处可能缺失具体物质名称]对鸡肠道健康和代谢调节的影响
Animals (Basel). 2025 Apr 29;15(9):1262. doi: 10.3390/ani15091262.
2
Revealing the antimicrobial potential of traditional Chinese medicine through text mining and molecular computation.通过文本挖掘和分子计算揭示中药的抗菌潜力。
Brief Bioinform. 2024 Nov 22;26(1). doi: 10.1093/bib/bbaf077.
3
anti- activity and the underlining mechanism of an empirical herbal formula - Hezi Qingyou.

本文引用的文献

1
Current and emerging drug treatment strategies to tackle invasive community-associated methicillin-resistant (MRSA) infection: what are the challenges?当前和新兴的药物治疗策略来应对侵袭性社区相关耐甲氧西林金黄色葡萄球菌(MRSA)感染:面临哪些挑战?
Expert Opin Pharmacother. 2023 Feb;24(3):331-346. doi: 10.1080/14656566.2022.2161885. Epub 2023 Jan 3.
2
Bactericidal activity of gallic acid against multi-drug resistance Escherichia coli.没食子酸对多重耐药大肠杆菌的杀菌活性。
Microb Pathog. 2022 Dec;173(Pt A):105824. doi: 10.1016/j.micpath.2022.105824. Epub 2022 Oct 13.
3
Revealing the novel effect of Jinghua Weikang capsule against the antibiotic resistance of .
经验性中药配方诃子清油的抗炎活性及潜在机制
Front Microbiol. 2024 Feb 19;15:1355460. doi: 10.3389/fmicb.2024.1355460. eCollection 2024.
揭示京华维康胶囊对抗……抗生素耐药性的新作用。 你提供的原文似乎不完整,“against the antibiotic resistance of”后面缺少具体内容。
Front Microbiol. 2022 Sep 6;13:962354. doi: 10.3389/fmicb.2022.962354. eCollection 2022.
4
A natural compound hyperoside targets Typhimurium T3SS needle protein InvG.一种天然化合物金丝桃苷靶向鼠伤寒沙门氏菌 T3SS 针状蛋白 InvG。
Food Funct. 2022 Oct 3;13(19):9761-9771. doi: 10.1039/d2fo00908k.
5
The water extract of Aloe vera prevents fluoxetine-induced multiple-drug resistance of E. coli by inhibiting reactive oxygen species formation and membrane permeability.库拉索芦荟水提取物通过抑制活性氧形成和膜通透性来预防氟西汀诱导的大肠杆菌多重耐药性。
Phytomedicine. 2022 Nov;106:154421. doi: 10.1016/j.phymed.2022.154421. Epub 2022 Aug 27.
6
Intestinal phages interact with bacteria and are involved in human diseases.肠道噬菌体与细菌相互作用,并与人类疾病有关。
Gut Microbes. 2022 Jan-Dec;14(1):2113717. doi: 10.1080/19490976.2022.2113717.
7
Isolation and Characterization of Galloylglucoses Effective against Multidrug-Resistant Strains of and .没食子酰基葡萄糖的分离与鉴定及其对耐多药 和 的活性
Molecules. 2022 Aug 8;27(15):5045. doi: 10.3390/molecules27155045.
8
Effects of Traditional Chinese Medicine and its Active Ingredients on Drug-Resistant Bacteria.中药及其活性成分对耐药菌的影响。
Front Pharmacol. 2022 Jun 2;13:837907. doi: 10.3389/fphar.2022.837907. eCollection 2022.
9
Drug Resistance and Epigenetic Modulatory Potential of Epigallocatechin-3-Gallate Against Staphylococcus aureus.表没食子儿茶素没食子酸酯对金黄色葡萄球菌的耐药性和表观遗传调节潜力。
Curr Microbiol. 2022 Apr 9;79(5):149. doi: 10.1007/s00284-022-02841-5.
10
Methicillin resistant Staphylococcus aureus: A brief review of virulence and resistance.耐甲氧西林金黄色葡萄球菌:毒力和耐药性的简要综述。
J Pak Med Assoc. 2022 Mar;72(3):509-515. doi: 10.47391/JPMA.0504.